- New drug profile - gefitinib (AstraZeneca)2005 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- New drug profile - gefitinib (AstraZeneca)2005 | Faculty of Medicine in Pilsen
- Decreasing neutralization antibody levels following vaccination against SARS-CoV-2 in the elderly: an observational study in Southern Moravia, Czech Republic2022 | First Faculty of Medicine
- Komentář ke studii CVD-REAL2017 | Second Faculty of Medicine
- Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialPublication without faculty affiliation
- Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry2022 | Faculty of Medicine in Hradec Králové
- Ticagrelor in Patients with Stable Coronary Disease and Diabetes2019 | Third Faculty of Medicine
- Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial2020 | Third Faculty of Medicine, Central Library of Charles University
- Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study2018 | Second Faculty of Medicine
- Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial2021 | Central Library of Charles University